1887

Journal of General Virology header logo

Volume 87, Issue 7

Kaposi's sarcoma-associated herpesvirus immune modulation: an overview Free

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is the most recently discovered human herpesvirus. It is the aetiological agent of Kaposi's sarcoma (KS), a tumour frequently affecting AIDS patients not receiving treatment. KSHV is also a likely cause of two lymphoproliferative diseases: multicentric Castleman's disease and primary effusion lymphoma. The study of KSHV offers exciting challenges for understanding the mechanisms of virus pathogenesis, including those involved in establishing infection and dissemination in the host. To facilitate these processes, approximately one-quarter of KSHV genes encode cellular homologues or unique proteins that have immunomodulatory roles in cytokine production, apoptosis, cell signalling and the immunological synapse. The activities of these molecules are considered in the present review and the positions of their genes are mapped from a complete KSHV genome sequence derived from a KS biopsy. The understanding gained enables the significance of different components of the immune response in protection against KSHV infection to be evaluated. It also helps to unravel the complexities of cellular and immunological pathways and offers the potential for exploiting viral immunomodulators and derivatives in disease therapy.

  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81919-0
2006-07-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/7/1781.html?itemId=/content/journal/jgv/10.1099/vir.0.81919-0&mimeType=html&fmt=ahah

References

  1. Albert M. L. 2004; Death-defying immunity: do apoptotic cells influence antigen processing and presentation?. Nat Rev Immunol 4:223–231 [CrossRef]
     [Google Scholar]
  2. Albrecht J.-C., Fleckenstein B. 1992; New member of the multigene family of complement control proteins in herpesvirus saimiri. J Virol 66:3937–3940
     [Google Scholar]
  3. Alcami A. 2003; Viral mimicry of cytokines, chemokines and their receptors. Nat Rev Immunol 3:36–50 [CrossRef]
     [Google Scholar]
  4. Alexander L., Denekamp L., Knapp A., Auerbach M. R., Damania B., Desrosiers R. C. 2000; The primary sequence of rhesus monkey rhadinovirus isolate 26-95: sequence similarities to Kaposi's sarcoma-associated herpesvirus and rhesus monkey rhadinovirus isolate 17577. J Virol 74:3388–3398 [CrossRef]
     [Google Scholar]
  5. Altieri D. C. 2003; Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22:8581–8589 [CrossRef]
     [Google Scholar]
  6. Ambroziak J. A., Blackbourn D. J., Herndier B. G., Glogau R. G., Gullett J. H., McDonald A. R., Lennette E. T., Levy J. A. 1995; Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 268:582–583 [CrossRef]
     [Google Scholar]
  7. An F.-Q., Compitello N., Horwitz E., Sramkoski M., Knudsen E. S., Renne R. 2005; The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest. J Biol Chem 280:3862–3874 [CrossRef]
     [Google Scholar]
  8. Andrejeva J., Childs K. S., Young D. F., Carlos T. S., Stock N., Goodbourn S., Randall R. E. 2004; The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN - β promoter. Proc Natl Acad Sci U S A 101:17264–17269 [CrossRef]
     [Google Scholar]
  9. Aoki Y., Jaffe E. S., Chang Y., Jones K., Teruya-Feldstein J., Moore P. S., Tosato G. 1999; Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 93:4034–4043
     [Google Scholar]
  10. Aoki Y., Yarchoan R., Braun J., Iwamoto A., Tosato G. 2000; Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions. Blood 96:1599–1601
     [Google Scholar]
  11. Arvanitakis L., Geras-Raaka E., Varma A., Gershengorn M. C., Cesarman E. 1997; Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385:347–350 [CrossRef]
     [Google Scholar]
  12. Bais C., Santomasso B., Coso O. & 7 other authors 1998; G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391:86–89 [CrossRef]
     [Google Scholar]
  13. Bais C., Van Geelen A., Eroles P., Mutlu A., Chiozzini C., Dias S., Silverstein R. L., Rafii S., Mesri E. A. 2003; Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/KDR. Cancer Cell 3:131–143 [CrossRef]
     [Google Scholar]
  14. Ballestas M. E., Chatis P. A., Kaye K. M. 1999; Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284:641–644 [CrossRef]
     [Google Scholar]
  15. Barbera A. J., Chodaparambil J. V., Kelley-Clarke B., Joukov V., Walter J. C., Luger K., Kaye K. M. 2006; The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science 311:856–861 [CrossRef]
     [Google Scholar]
  16. Barclay A. N., Wright G. J., Brooke G., Brown M. H. 2002; CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol 23:285–290 [CrossRef]
     [Google Scholar]
  17. Batista F. D., Iber D., Neuberger M. S. 2001; B cells acquire antigen from target cells after synapse formation. Nature 411:489–494 [CrossRef]
     [Google Scholar]
  18. Bechtel J., Grundhoff A., Ganem D. 2005; RNAs in the virion of Kaposi's sarcoma-associated herpesvirus. J Virol 79:10138–10146 [CrossRef]
     [Google Scholar]
  19. Benedict C. A., Norris P. S., Ware C. F. 2002; To kill or be killed: viral evasion of apoptosis. Nat Immunol 3:1013–1018 [CrossRef]
     [Google Scholar]
  20. Blue C. E., Spiller O. B., Blackbourn D. J. 2004; The relevance of complement to virus biology. Virology 319:176–184 [CrossRef]
     [Google Scholar]
  21. Boehme K. W., Compton T. 2004; Innate sensing of viruses by Toll-like receptors. J Virol 78:7867–7873 [CrossRef]
     [Google Scholar]
  22. Boshoff C., Endo Y., Collins P. D. & 10 other authors 1997; Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 278:290–294 [CrossRef]
     [Google Scholar]
  23. Boulanger M. J., Chow D.-C., Brevnova E., Martick M., Sandford G., Nicholas J., Garcia K. C. 2004; Molecular mechanisms for viral mimicry of a human cytokine: activation of gp130 by HHV-8 interleukin-6. J Mol Biol 335:641–654 [CrossRef]
     [Google Scholar]
  24. Bower J. F., Green T. D., Ross T. M. 2004; DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1. Virology 328:292–300 [CrossRef]
     [Google Scholar]
  25. Brander C., Suscovich T., Lee Y. & 7 other authors 2000; Impaired CTL recognition of cells latently infected with Kaposi's sarcoma-associated herpes virus. J Immunol 165:2077–2083 [CrossRef]
     [Google Scholar]
  26. Brinkmann M. M., Glenn M., Rainbow L., Kieser A., Henke-Gendo C., Schulz T. F. 2003; Activation of mitogen-activated protein kinase and NF- κ B pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein. J Virol 77:9346–9358 [CrossRef]
     [Google Scholar]
  27. Brown L. F., Tognazzi K., Dvorak H. F., Harrist T. J. 1996; Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol 148:1065–1074
     [Google Scholar]
  28. Burger R., Wendler J., Antoni K., Helm G., Kalden J. R., Gramatzki M. 1994; Interleukin-6 production in B-cell neoplasias and Castleman's disease: evidence for an additional paracrine loop. Ann Hematol 69:25–31 [CrossRef]
     [Google Scholar]
  29. Burger R., Neipel F., Fleckenstein B., Savino R., Ciliberto G., Kalden J. R., Gramatzki M. 1998; Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells. Blood 91:1858–1863
     [Google Scholar]
  30. Burýšek L., Pitha P. M. 2001; Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase. J Virol 75:2345–2352 [CrossRef]
     [Google Scholar]
  31. Burýšek L., Yeow W.-S., Pitha P. M. 1999a; Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2). J Hum Virol 2:19–32
     [Google Scholar]
  32. Burýšek L., Yeow W.-S., Lubyová B., Kellum M., Schafer S. L., Huang Y. Q., Pitha P. M. 1999b; Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J Virol 73:7334–7342
     [Google Scholar]
  33. Cadwell K., Coscoy L. 2005; Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 309:127–130 [CrossRef]
     [Google Scholar]
  34. Cai X., Lu S., Zhang Z., Gonzalez C. M., Damania B., Cullen B. R. 2005; Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci U S A 102:5570–5575 [CrossRef]
     [Google Scholar]
  35. Cannon M. L., Cesarman E. 2004; The KSHV G protein-coupled receptor signals via multiple pathways to induce transcription factor activation in primary effusion lymphoma cells. Oncogene 23:514–523 [CrossRef]
     [Google Scholar]
  36. Cannon J. S., Nicholas J., Orenstein J. M. & 7 other authors 1999; Heterogeneity of viral IL-6 expression in HHV-8-associated diseases. J Infect Dis 180:824–828 [CrossRef]
     [Google Scholar]
  37. Cannon M., Cesarman E., Boshoff C. 2006; KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2. Blood 107:277–284 [CrossRef]
     [Google Scholar]
  38. Cesarman E., Nador R. G., Bai F., Bohenzky R. A., Russo J. J., Moore P. S., Chang Y., Knowles D. M. 1996; Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol 70:8218–8223
     [Google Scholar]
  39. Cesarman E., Mesri E. A., Gershengorn M. C. 2000; Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia?. J Exp Med 191:417–422 [CrossRef]
     [Google Scholar]
  40. Chang Y., Cesarman E., Pessin M. S., Lee F., Culpepper J., Knowles D. M., Moore P. S. 1994; Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865–1869 [CrossRef]
     [Google Scholar]
  41. Chatterjee M., Osborne J., Bestetti G., Chang Y., Moore P. S. 2002; Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298:1432–1435 [CrossRef]
     [Google Scholar]
  42. Chaudhary P. M., Jasmin A., Eby M. T., Hood L. 1999; Modulation of the NF- κ B pathway by virally encoded death effector domains-containing proteins. Oncogene 18:5738–5746 [CrossRef]
     [Google Scholar]
  43. Chen J., Ueda K., Sakakibara S., Okuno T., Yamanishi K. 2000; Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene. J Virol 74:8623–8634 [CrossRef]
     [Google Scholar]
  44. Cheng E. H.-Y., Nicholas J., Bellows D. S., Hayward G. S., Guo H.-G., Reitz M. S., Hardwick J. M. 1997; A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci U S A 94:690–694 [CrossRef]
     [Google Scholar]
  45. Choi J.-K., Lee B.-S., Shim S. N., Li M., Jung J. U. 2000; Identification of the novel K15 gene at the rightmost end of the Kaposi's sarcoma-associated herpesvirus genome. J Virol 74:436–446 [CrossRef]
     [Google Scholar]
  46. Chugh P., Matta H., Schamus S., Zachariah S., Kumar A., Richardson J. A., Smith A. L., Chaudhary P. M. 2005; Constitutive NF- κ B activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice. Proc Natl Acad Sci U S A 102:12885–12890 [CrossRef]
     [Google Scholar]
  47. Chung Y.-H., Means R. E., Choi J.-K., Lee B.-S., Jung J. U. 2002; Kaposi's sarcoma-associated herpesvirus OX2 glycoprotein activates myeloid-lineage cells to induce inflammatory cytokine production. J Virol 76:4688–4698 [CrossRef]
     [Google Scholar]
  48. Cilenti L., Soundarapandian M. M., Kyriazis G. A., Stratico V., Singh S., Gupta S., Bonventre J. V., Alnemri E. S., Zervos A. S. 2004; Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death. J Biol Chem 279:50295–50301 [CrossRef]
     [Google Scholar]
  49. Cohen A., Wolf D. G., Guttman-Yassky E., Sarid R. 2005; Kaposi's sarcoma-associated herpesvirus: clinical, diagnostic, and epidemiological aspects. Crit Rev Clin Lab Sci 42:101–153 [CrossRef]
     [Google Scholar]
  50. Cornali E., Zietz C., Benelli R., Weninger W., Masiello L., Breier G., Tschachler E., Albini A., Stürzl M. 1996; Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am J Pathol 149:1851–1869
     [Google Scholar]
  51. Coscoy L., Ganem D. 2000; Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci U S A 97:8051–8056 [CrossRef]
     [Google Scholar]
  52. Coscoy L., Ganem D. 2001; A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. J Clin Invest 107:1599–1606 [CrossRef]
     [Google Scholar]
  53. Coscoy L., Sanchez D. J., Ganem D. 2001; A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition. J Cell Biol 155:1265–1273 [CrossRef]
     [Google Scholar]
  54. Cosmi L., Annunziato F., Maggi E., Romagnani S., Manetti R. 2001; Chemoattractant receptors expressed on type 2 T cells and their role in disease. Int Arch Allergy Immunol 125:273–279 [CrossRef]
     [Google Scholar]
  55. Crozat K., Beutler B. 2004; TLR7: a new sensor of viral infection. Proc Natl Acad Sci U S A 101:6835–6836 [CrossRef]
     [Google Scholar]
  56. Cunningham C., Barnard S., Blackbourn D. J., Davison A. J. 2003; Transcription mapping of human herpesvirus 8 genes encoding viral interferon regulatory factors. J Gen Virol 84:1471–1483 [CrossRef]
     [Google Scholar]
  57. Dairaghi D. J., Fan R. A., McMaster B. E., Hanley M. R., Schall T. J. 1999; HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines. J Biol Chem 274:21569–21574 [CrossRef]
     [Google Scholar]
  58. Danial N. N., Korsmeyer S. J. 2004; Cell death: critical control points. Cell 116:205–219 [CrossRef]
     [Google Scholar]
  59. Davis D. M., Chiu I., Fassett M., Cohen G. B., Mandelboim O., Strominger J. L. 1999; The human natural killer cell immune synapse. Proc Natl Acad Sci U S A 96:15062–15067 [CrossRef]
     [Google Scholar]
  60. Decker T., Kovarik P., Meinke A. 1997; GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J Interferon Cytokine Res 17:121–134 [CrossRef]
     [Google Scholar]
  61. Dittmer D. P. 2003; Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays. Cancer Res 63:2010–2015
     [Google Scholar]
  62. Djerbi M., Screpanti V., Catrina A. I., Bogen B., Biberfeld P., Grandien A. 1999; The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J Exp Med 190:1025–1032 [CrossRef]
     [Google Scholar]
  63. Ensoli B., Stürzl M. 1998; Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev 9:63–83 [CrossRef]
     [Google Scholar]
  64. Escalante C. R., Yie J., Thanos D., Aggarwal A. K. 1998; Structure of IRF-1 with bound DNA reveals determinants of interferon regulation. Nature 391:103–106 [CrossRef]
     [Google Scholar]
  65. Fakhari F. D., Dittmer D. P. 2002; Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR. J Virol 76:6213–6223 [CrossRef]
     [Google Scholar]
  66. Fauci A. S. 1996; Host factors and the pathogenesis of HIV-induced disease. Nature 384:529–534 [CrossRef]
     [Google Scholar]
  67. Fielding C. A., McLoughlin R. M., Colmont C. S., Kovaleva M., Harris D. A., Rose-John S., Topley N., Jones S. A. 2005; Viral IL-6 blocks neutrophil infiltration during acute inflammation. J Immunol 175:4024–4029 [CrossRef]
     [Google Scholar]
  68. Fitzgerald K. A., McWhirter S. M., Faia K. L., Rowe D. C., Latz E., Golenbock D. T., Coyle A. J., Liao S.-M., Maniatis T. 2003; IKK ε and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4:491–496
     [Google Scholar]
  69. Flowers C. C., Flowers S. P., Nabel G. J. 1998; Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor confers resistance to the antiproliferative effect of interferon-alpha. Mol Med 4:402–412
     [Google Scholar]
  70. Foster-Cuevas M., Wright G. J., Puklavec M. J., Brown M. H., Barclay A. N. 2004; Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor. J Virol 78:7667–7676 [CrossRef]
     [Google Scholar]
  71. Foy E., Li K., Wang C., Sumpter R. Jr, Ikeda M., Lemon S. M., Gale M., Jr. 2003; Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300:1145–1148 [CrossRef]
     [Google Scholar]
  72. Friborg J. Jr, Kong W., Hottiger M. O., Nabel G. J. 1999; p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402:889–894
     [Google Scholar]
  73. Friedl P., den Boer A. T., Gunzer M. 2005; Tuning immune responses: diversity and adaptation of the immunological synapse. Nat Rev Immunol 5:532–545 [CrossRef]
     [Google Scholar]
  74. Fuld S., Cunningham C., Klucher K., Davison A. J., Blackbourn D. J. 2006; Inhibition of interferon signaling by the Kaposi's sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein. J Virol 80:3092–3097 [CrossRef]
     [Google Scholar]
  75. Gao S.-J., Boshoff C., Jayachandra S., Weiss R. A., Chang Y., Moore P. S. 1997; KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 15:1979–1985 [CrossRef]
     [Google Scholar]
  76. Gershengorn M. C., Geras-Raaka E., Varma A., Clark-Lewis I. 1998; Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture. J Clin Invest 102:1469–1472 [CrossRef]
     [Google Scholar]
  77. Glaunsinger B., Ganem D. 2004a; Highly selective escape from KSHV-mediated host mRNA shutoff and its implications for viral pathogenesis. J Exp Med 200:391–398 [CrossRef]
     [Google Scholar]
  78. Glaunsinger B., Ganem D. 2004b; Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. Mol Cell 13:713–723 [CrossRef]
     [Google Scholar]
  79. Glaunsinger B., Chavez L., Ganem D. 2005; The exonuclease and host shutoff functions of the SOX protein of Kaposi's sarcoma-associated herpesvirus are genetically separable. J Virol 79:7396–7401 [CrossRef]
     [Google Scholar]
  80. Glenn M., Rainbow L., Auradé F., Davison A., Schulz T. F. 1999; Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus. J Virol 73:6953–6963
     [Google Scholar]
  81. Godfrey A., Anderson J., Papanastasiou A., Takeuchi Y., Boshoff C. 2005; Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. Blood 105:2510–2518 [CrossRef]
     [Google Scholar]
  82. Goodbourn S., Didcock L., Randall R. E. 2000; Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 81:2341–2364
     [Google Scholar]
  83. Gorczynski R. M., Yu K., Clark D. 2000; Receptor engagement on cells expressing a ligand for the tolerance-inducing molecule OX2 induces an immunoregulatory population that inhibits alloreactivity in vitro and in vivo. J Immunol 165:4854–4860 [CrossRef]
     [Google Scholar]
  84. Gorczynski R., Chen Z., Kai Y., Lee L., Wong S., Marsden P. A. 2004a; CD200 is a ligand for all members of the CD200R family of immunoregulatory molecules. J Immunol 172:7744–7749 [CrossRef]
     [Google Scholar]
  85. Gorczynski R. M., Chen Z., Clark D. A., Kai Y., Lee L., Nachman J., Wong S., Marsden P. 2004b; Structural and functional heterogeneity in the CD200R family of immunoregulatory molecules and their expression at the feto-maternal interface. Am J Reprod Immunol 52:147–163 [CrossRef]
     [Google Scholar]
  86. Graham K. A., Lalani A. S., Macen J. L. 7 other authors 1997; The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology 229:12–24 [CrossRef]
     [Google Scholar]
  87. Grakoui A., Bromley S. K., Sumen C., Davis M. M., Shaw A. S., Allen P. M., Dustin M. L. 1999; The immunological synapse: a molecular machine controlling T cell activation. Science 285:221–227 [CrossRef]
     [Google Scholar]
  88. Grundhoff A., Ganem D. 2004; Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest 113:124–136 [CrossRef]
     [Google Scholar]
  89. Guasparri I., Keller S. A., Cesarman E. 2004; KSHV vFLIP is essential for the survival of infected lymphoma cells. J Exp Med 199:993–1003 [CrossRef]
     [Google Scholar]
  90. Guasparri I., Wu H., Cesarman E. 2006; The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling. EMBO Rep 7:114–119 [CrossRef]
     [Google Scholar]
  91. Gwack Y., Hwang S., Byun H., Lim C., Kim J. W., Choi E.-J., Choe J. 2001; Kaposi's sarcoma-associated herpesvirus open reading frame 50 represses p53-induced transcriptional activity and apoptosis. J Virol 75:6245–6248 [CrossRef]
     [Google Scholar]
  92. Harada H., Taniguchi T., Tanaka N. 1998; The role of interferon regulatory factors in the interferon system and cell growth control. Biochimie 80:641–650 [CrossRef]
     [Google Scholar]
  93. Harris R. S., Bishop K. N., Sheehy A. M., Craig H. M., Petersen-Mahrt S. K., Watt I. N., Neuberger M. S., Malim M. H. 2003; DNA deamination mediates innate immunity to retroviral infection. Cell 113:803–809 [CrossRef]
     [Google Scholar]
  94. Hegde N. R., Johnson D. C. 2005; A seek-and-hide game between Cd1-restricted T cells and herpesviruses. J Clin Invest 115:1146–1149 [CrossRef]
     [Google Scholar]
  95. Hewitt E. W., Duncan L., Mufti D., Baker J., Stevenson P. G., Lehner P. J. 2002; Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101-dependent degradation. EMBO J 21:2418–2429 [CrossRef]
     [Google Scholar]
  96. Hideshima T., Chauhan D., Teoh G., Raje N., Treon S. P., Tai Y.-T., Shima Y., Anderson K. C. 2000; Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6. Clin Cancer Res 6:1180–1189
     [Google Scholar]
  97. Hodge D. R., Hurt E. M., Farrar W. L. 2005; The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 41:2502–2512 [CrossRef]
     [Google Scholar]
  98. Honda K., Yanai H., Negishi H. & 8 other authors 2005; IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772–777 [CrossRef]
     [Google Scholar]
  99. Huang Q., Petros A. M., Virgin H. W., Fesik S. W., Olejniczak E. T. 2002; Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus. Proc Natl Acad Sci U S A 99:3428–3433 [CrossRef]
     [Google Scholar]
  100. Irmler M., Thome M., Hahne M. & 10 other authors 1997; Inhibition of death receptor signals by cellular FLIP. Nature 388:190–195 [CrossRef]
     [Google Scholar]
  101. Isaacs A., Lindenmann J. 1957; Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147:258–267 [CrossRef]
     [Google Scholar]
  102. Ishido S., Wang C., Lee B.-S., Cohen G. B., Jung J. U. 2000a; Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol 74:5300–5309 [CrossRef]
     [Google Scholar]
  103. Ishido S., Choi J. K., Lee B. S., Wang C., DeMaria M., Johnson R. P., Cohen G. B., Jung J. U. 2000b; Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity 13:365–374 [CrossRef]
     [Google Scholar]
  104. Jenner R. G., Albà M. M., Boshoff C., Kellam P. 2001; Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J Virol 75:891–902 [CrossRef]
     [Google Scholar]
  105. Keller S. A., Schattner E. J., Cesarman E. 2000; Inhibition of NF- κ B induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood 96:2537–2542
     [Google Scholar]
  106. King P., Goodbourn S. 1994; The β -interferon promoter responds to priming through multiple independent regulatory elements. J Biol Chem 269:30609–30615
     [Google Scholar]
  107. Kirchhoff S., Sebens T., Baumann S. & 7 other authors 2002; Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter. J Immunol 168:1226–1234 [CrossRef]
     [Google Scholar]
  108. Kirkitadze M. D., Barlow P. N. 2001; Structure and flexibility of the multiple domain proteins that regulate complement activation. Immunol Rev 180:146–161 [CrossRef]
     [Google Scholar]
  109. Kledal T. N., Rosenkilde M. M., Coulin F. & 10 other authors 1997; A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science 277:1656–1659 [CrossRef]
     [Google Scholar]
  110. Kliche S., Nagel W., Kremmer E., Atzler C., Ege A., Knorr T., Koszinowski U., Kolanus W., Haas J. 2001; Signaling by human herpesvirus 8 kaposin A through direct membrane recruitment of cytohesin-1 . Mol Cell 7:833–843 [CrossRef]
     [Google Scholar]
  111. Kotenko S. V., Gallagher G., Baurin V. V. & 7 other authors 2003; IFN- λ s mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4:69–77
     [Google Scholar]
  112. Krishnan H. H., Naranatt P. P., Smith M. S., Zeng L., Bloomer C., Chandran B. 2004; Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J Virol 78:3601–3620 [CrossRef]
     [Google Scholar]
  113. Lagunoff M., Ganem D. 1997; The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. Virology 236:147–154 [CrossRef]
     [Google Scholar]
  114. Lagunoff M., Majeti R., Weiss A., Ganem D. 1999; Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 96:5704–5709 [CrossRef]
     [Google Scholar]
  115. Lagunoff M., Lukac D. M., Ganem D. 2001; Immunoreceptor tyrosine-based activation motif-dependent signaling by Kaposi's sarcoma-associated herpesvirus K1 protein: effects on lytic viral replication. J Virol 75:5891–5898 [CrossRef]
     [Google Scholar]
  116. Lalani A. S., Barrett J. W., McFadden G. 2000; Modulating chemokines: more lessons from viruses. Immunol Today 21:100–106 [CrossRef]
     [Google Scholar]
  117. Lee H., Guo J., Li M., Choi J.-K., DeMaria M., Rosenzweig M., Jung J. U. 1998a; Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Mol Cell Biol 18:5219–5228
     [Google Scholar]
  118. Lee H., Veazey R., Williams K. & 7 other authors (1998b). Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat Med 4:435–440 [CrossRef]
     [Google Scholar]
  119. Lee B.-S., Alvarez X., Ishido S., Lackner A. A., Jung J. U. 2000; Inhibition of intracellular transport of B cell antigen receptor complexes by Kaposi's sarcoma-associated herpesvirus K1. J Exp Med 192:11–21 [CrossRef]
     [Google Scholar]
  120. Lee B.-S., Paulose-Murphy M., Chung Y. H., Connlole M., Zeichner S., Jung J. U. 2002; Suppression of tetradecanoyl phorbol acetate-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus by K1 signal transduction. J Virol 76:12185–12199 [CrossRef]
     [Google Scholar]
  121. Lee B.-S., Lee S.-H., Feng P., Chang H., Cho N.-H., Jung J. U. 2005; Characterization of the Kaposi's sarcoma-associated herpesvirus K1 signalosome. J Virol 79:12173–12184 [CrossRef]
     [Google Scholar]
  122. Levy D. E., Marié I. J. 2004; RIGging an antiviral defense – it's in the CARDs. Nat Immunol 5:699–701
     [Google Scholar]
  123. Li M., Damania B., Alvarez X., Ogryzko V., Ozato K., Jung J. U. 2000; Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor. Mol Cell Biol 20:8254–8263 [CrossRef]
     [Google Scholar]
  124. Lieberman J. 2003; The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat Rev Immunol 3:361–370 [CrossRef]
     [Google Scholar]
  125. Lilley B. N., Ploegh H. L. 2005; Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond. Immunol Rev 207:126–144 [CrossRef]
     [Google Scholar]
  126. Lin R., Genin P., Mamane Y., Sgarbanti M., Battistini A., Harrington W. J. Jr, Barber G. N., Hiscott J. 2001; HHV-8-encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene 20:800–811 [CrossRef]
     [Google Scholar]
  127. Liu C., Okruzhnov Y., Li H., Nicholas J. 2001; Human herpesvirus 8 (HHV-8)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent antiapoptotic effects. J Virol 75:10933–10940 [CrossRef]
     [Google Scholar]
  128. Lodoen M. B., Lanier L. L. 2005; Viral modulation of NK cell immunity. Nat Rev Microbiol 3:59–69 [CrossRef]
     [Google Scholar]
  129. Lowe S. W., Cepero E., Evan G. 2004; Intrinsic tumour suppression. Nature 432:307–315 [CrossRef]
     [Google Scholar]
  130. Lubyova B., Pitha P. M. 2000; Characterization of a novel human herpesvirus 8-encoded protein, vIRF- 3, that shows homology to viral and cellular interferon regulatory factors. J Virol 74:8194–8201 [CrossRef]
     [Google Scholar]
  131. Lubyova B., Kellum M. J., Frisancho A. J., Pitha P. M. 2004; Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7. J Biol Chem 279:7643–7654 [CrossRef]
     [Google Scholar]
  132. Masood R., Cai J., Zheng T., Smith D. L., Naidu Y., Gill P. S. 1997; Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS–Kaposi sarcoma. Proc Natl Acad Sci U S A 94:979–984 [CrossRef]
     [Google Scholar]
  133. McCormick C., Ganem D. 2005; The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs. Science 307:739–741 [CrossRef]
     [Google Scholar]
  134. McGeoch D. J. 2001; Molecular evolution of the γ - Herpesvirinae . Philos Trans R Soc Lond B Biol Sci 356:421–435 [CrossRef]
     [Google Scholar]
  135. McGuirk P., Mills K. H. G. 2002; Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol 23:450–455 [CrossRef]
     [Google Scholar]
  136. Miles S. A., Rezai A. R., Salazar-González J. F. & 8 other authors 1990; AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci U S A 87:4068–4072 [CrossRef]
     [Google Scholar]
  137. Milligan S., Robinson M., O'Donnell E., Blackbourn D. J. 2004; Inflammatory cytokines inhibit Kaposi's sarcoma-associated herpesvirus lytic gene transcription in in vitro-infected endothelial cells. J Virol 78:2591–2596 [CrossRef]
     [Google Scholar]
  138. Molden J., Chang Y., You Y., Moore P. S., Goldsmith M. A. 1997; A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem 272:19625–19631 [CrossRef]
     [Google Scholar]
  139. Monks C. R. F., Freiberg B. A., Kupfer H., Sciaky N., Kupfer A. 1998; Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395:82–86 [CrossRef]
     [Google Scholar]
  140. Montaner S., Sodhi A., Servitja J.-M., Ramsdell A. K., Barac A., Sawai E. T., Gutkind J. S. 2004; The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia. Blood 104:2903–2911 [CrossRef]
     [Google Scholar]
  141. Moore P. S., Chang Y. 2003; Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin?. Annu Rev Microbiol 57:609–639 [CrossRef]
     [Google Scholar]
  142. Moore P. S., Boshoff C., Weiss R. A., Chang Y. 1996; Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274:1739–1744 [CrossRef]
     [Google Scholar]
  143. Morris R. J., Beech J. N. 1987; Sequential expression of OX2 and Thy-1 glycoproteins on the neuronal surface during development. An immunohistochemical study of rat cerebellum. Dev Neurosci 9:33–44 [CrossRef]
     [Google Scholar]
  144. Müllberg J., Geib T., Jostock T. & 7 other authors 2000; IL-6 receptor independent stimulation of human gp130 by viral IL-6. J Immunol 164:4672–4677 [CrossRef]
     [Google Scholar]
  145. Mullick J., Bernet J., Singh A. K., Lambris J. D., Sahu A. 2003; Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) open reading frame 4 protein (kaposica) is a functional homolog of complement control proteins. J Virol 77:3878–3881 [CrossRef]
     [Google Scholar]
  146. Muralidhar S., Pumfery A. M., Hassani M. & 7 other authors 1998; Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J Virol 72:4980–4988
     [Google Scholar]
  147. Murphy P. M. 2001; Viral exploitation and subversion of the immune system through chemokine mimicry. Nat Immunol 2:116–122 [CrossRef]
     [Google Scholar]
  148. Nakamura S., Murakami-Mori K., Rao N., Weich H. A., Rajeev B. 1997; Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells. J Immunol 158:4992–5001
     [Google Scholar]
  149. Nakamura H., Li M., Zarycki J., Jung J. U. 2001; Inhibition of p53 tumor suppressor by viral interferon regulatory factor. J Virol 75:7572–7582 [CrossRef]
     [Google Scholar]
  150. Neipel F., Albrecht J.-C., Fleckenstein B. 1997a; Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity?. J Virol 71:4187–4192
     [Google Scholar]
  151. Neipel F., Albrecht J.-C., Ensser A., Huang Y.-Q., Li J. J., Friedman-Kien A. E., Fleckenstein B. 1997b; Human herpesvirus 8 encodes a homolog of interleukin-6. J Virol 71:839–842
     [Google Scholar]
  152. Nguyen H., Hiscott J., Pitha P. M. 1997; The growing family of interferon regulatory factors. Cytokine Growth Factor Rev 8:293–312 [CrossRef]
     [Google Scholar]
  153. Nicholas J. 2003; Human herpesvirus-8-encoded signalling ligands and receptors. J Biomed Sci 10:475–489 [CrossRef]
     [Google Scholar]
  154. Nicholas J. 2005; Human gammaherpesvirus cytokines and chemokine receptors. J Interferon Cytokine Res 25:373–383 [CrossRef]
     [Google Scholar]
  155. Nicholas J., Ruvolo V., Zong J., Ciufo D., Guo H. G., Reitz M. S., Hayward G. S. 1997a; A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins. J Virol 71:1963–1974
     [Google Scholar]
  156. Nicholas J., Ruvolo V. R., Burns W. H. & 7 other authors (1997b). Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med 3:287–292 [CrossRef]
     [Google Scholar]
  157. O'Garra A., Arai N. 2000; The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol 10:542–550 [CrossRef]
     [Google Scholar]
  158. Ojala P. M., Yamamoto K., Castaños-Vélez E., Biberfeld P., Korsmeyer S. J., Mäkelä T. P. 2000; The apoptotic v-cyclin–CDK6 complex phosphorylates and inactivates Bcl-2. Nat Cell Biol 2:819–825 [CrossRef]
     [Google Scholar]
  159. Osborne J., Moore P. S., Chang Y. 1999; KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Hum Immunol 60:921–927 [CrossRef]
     [Google Scholar]
  160. Park J., Seo T., Hwang S., Lee D., Gwack Y., Choe J. 2000; The K-bZIP protein from Kaposi's sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity. J Virol 74:11977–11982 [CrossRef]
     [Google Scholar]
  161. Parravicini C., Chandran B., Corbellino M., Berti E., Paulli M., Moore P. S., Chang Y. 2000; Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol 156:743–749 [CrossRef]
     [Google Scholar]
  162. Parry C. M., Simas J. P., Smith V. P., Stewart C. A., Minson A. C., Efstathiou S., Alcami A. 2000; A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J Exp Med 191:573–578 [CrossRef]
     [Google Scholar]
  163. Pati S., Cavrois M., Guo H.-G., Foulke J. S., Kim J., Jr, Feldman R. A., Reitz M. 2001; Activation of NF- κ B by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis. J Virol 75:8660–8673 [CrossRef]
     [Google Scholar]
  164. Paulose-Murphy M., Ha N.-K., Xiang C. & 7 other authors 2001; Transcription program of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus). J Virol 75:4843–4853 [CrossRef]
     [Google Scholar]
  165. Penfold M. E. T., Dairaghi D. J., Duke G. M., Saederup N., Mocarski E. S., Kemble G. W., Schall T. J. 1999; Cytomegalovirus encodes a potent α chemokine. Proc Natl Acad Sci U S A 96:9839–9844 [CrossRef]
     [Google Scholar]
  166. Pestka S., Krause C. D., Walter M. R. 2004; Interferons, interferon-like cytokines, and their receptors. Immunol Rev 202:8–32 [CrossRef]
     [Google Scholar]
  167. Pfeffer S., Sewer A., Lagos-Quintana M. & 16 other authors 2005; Identification of microRNAs of the herpesvirus family. Nat Methods 2:269–276 [CrossRef]
     [Google Scholar]
  168. Pitha P. M., Au W.-C., Lowther W., Juang Y.-T., Schafer S. L., Burýšek L., Hiscott J., Moore P. A. 1998; Role of the interferon regulatory factors (IRFs) in virus-mediated signaling and regulation of cell growth. Biochimie 80:651–658 [CrossRef]
     [Google Scholar]
  169. Poole L. J., Zong J.-C., Ciufo D. M., Alcendor D. J., Cannon J. S., Ambinder R., Orenstein J. M., Reitz M. S., Hayward G. S. 1999; Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end. J Virol 73:6646–6660
     [Google Scholar]
  170. Pozharskaya V. P., Weakland L. L., Zimring J. C., Krug L. T., Unger E. R., Neisch A., Joshi H., Inoue N., Offermann M. K. 2004; Short duration of elevated vIRF-1 expression during lytic replication of human herpesvirus 8 limits its ability to block antiviral responses induced by alpha interferon in BCBL-1 cells. J Virol 78:6621–6635 [CrossRef]
     [Google Scholar]
  171. Prakash O., Swamy O. R., Peng X. & 8 other authors 2005; Activation of Src kinase Lyn by the Kaposi sarcoma-associated herpesvirus K1 protein: implications for lymphomagenesis. Blood 105:3987–3994 [CrossRef]
     [Google Scholar]
  172. Purbhoo M. A., Irvine D. J., Huppa J. B., Davis M. M. 2004; T cell killing does not require the formation of a stable mature immunological synapse. Nat Immunol 5:524–530 [CrossRef]
     [Google Scholar]
  173. Radkov S. A., Kellam P., Boshoff C. 2000; The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma–E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 6:1121–1127 [CrossRef]
     [Google Scholar]
  174. Rezaee S. A. R., Gracie J. A., McInnes I. B., Blackbourn D. J. 2005; Inhibition of neutrophil function by the Kaposi's sarcoma-associated herpesvirus vOX2 protein. AIDS 19:1907–1910 [CrossRef]
     [Google Scholar]
  175. Rivas C., Thlick A.-E., Parravicini C., Moore P. S., Chang Y. 2001; Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol 75:429–438 [CrossRef]
     [Google Scholar]
  176. Roan F., Zimring J. C., Goodbourn S., Offermann M. K. 1999; Transcriptional activation by the human herpesvirus-8-encoded interferon regulatory factor. J Gen Virol 80:2205–2209
     [Google Scholar]
  177. Rot A., von Andrian U. H. 2004; Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 22:891–928 [CrossRef]
     [Google Scholar]
  178. Russo J. J., Bohenzky R. A., Chien M.-C. & 8 other authors 1996; Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 93:14862–14867 [CrossRef]
     [Google Scholar]
  179. Sadler R., Wu L., Forghani B., Renne R., Zhong W., Herndier B., Ganem D. 1999; A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J Virol 73:5722–5730
     [Google Scholar]
  180. Samols M. A., Hu J., Skalsky R. L., Renne R. 2005; Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J Virol 79:9301–9305 [CrossRef]
     [Google Scholar]
  181. Sanchez D. J., Gumperz J. E., Ganem D. 2005; Regulation of CD1d expression and function by a herpesvirus infection. J Clin Invest 115:1369–1378 [CrossRef]
     [Google Scholar]
  182. Sarid R., Sato T., Bohenzky R. A., Russo J. J., Chang Y. 1997; Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat Med 3:293–298 [CrossRef]
     [Google Scholar]
  183. Sarid R., Flore O., Bohenzky R. A., Chang Y., Moore P. S. 1998; Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol 72:1005–1012
     [Google Scholar]
  184. Schimmer A. D., Dalili S. 2005; Targeting the IAP family of caspase inhibitors as an emerging therapeutic strategy. Hematology (Am Soc Hematol Educ Program), 215–219
  185. Schulz T. F. 1998; Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). J Gen Virol 79:1573–1591
     [Google Scholar]
  186. Schwarz M., Murphy P. M. 2001; Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor constitutively activates NF- κ B and induces proinflammatory cytokine and chemokine production via a C-terminal signaling determinant. J Immunol 167:505–513 [CrossRef]
     [Google Scholar]
  187. Schwarze M. M., Hawley R. G. 1995; Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL. Cancer Res 55:2262–2265
     [Google Scholar]
  188. Searles R. P., Bergquam E. P., Axthelm M. K., Wong S. W. 1999; Sequence and genomic analysis of a rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J Virol 73:3040–3053
     [Google Scholar]
  189. Sen G. C., Sarkar S. N. 2005a; Transcriptional signaling by double-stranded RNA: role of TLR3. Cytokine Growth Factor Rev 16:1–14 [CrossRef]
     [Google Scholar]
  190. Sen G. C., Sarkar S. N. 2005b; Hitching RIG to action. Nat Immunol 6:1074–1076 [CrossRef]
     [Google Scholar]
  191. Seo T., Park J., Lee D., Hwang S. G., Choe J. 2001; Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis. J Virol 75:6193–6198 [CrossRef]
     [Google Scholar]
  192. Seo T., Park J., Choe J. 2005; Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor- β signaling. Cancer Res 65:1738–1747 [CrossRef]
     [Google Scholar]
  193. Servant M. J., ten Oever B., LePage C., Conti L., Gessani S., Julkunen I., Lin R., Hiscott J. 2001; Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3. J Biol Chem 276:355–363 [CrossRef]
     [Google Scholar]
  194. Sharma S., ten Oever B. R., Grandvaux N., Zhou G.-P., Lin R., Hiscott J. 2003; Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148–1151 [CrossRef]
     [Google Scholar]
  195. Sharp T. V., Wang H.-W., Koumi A., Hollyman D., Endo Y., Ye H., Du M.-Q., Boshoff C. 2002; K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J Virol 76:802–816 [CrossRef]
     [Google Scholar]
  196. Sheehy A. M., Gaddis N. C., Choi J. D., Malim M. H. 2002; Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646–650 [CrossRef]
     [Google Scholar]
  197. Sheppard P., Kindsvogel W., Xu W. & 23 other authors 2003; IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4:63–68 [CrossRef]
     [Google Scholar]
  198. Shin Y. C., Nakamura H., Liang X., Feng P., Chang H., Kowalik T. F., Jung J. U. 2006; Inhibition of the ATM/p53 signal transduction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1. J Virol 80:2257–2266 [CrossRef]
     [Google Scholar]
  199. Smith E. J., Marié I., Prakash A., García-Sastre A., Levy D. E. 2001; IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or I κ B kinase but is blocked by vaccinia virus E3L protein. J Biol Chem 276:8951–8957 [CrossRef]
     [Google Scholar]
  200. Sozzani S., Luini W., Bianchi G. & 12 other authors 1998; The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood 92:4036–4039
     [Google Scholar]
  201. Spiller O. B., Blackbourn D. J., Mark L., Proctor D. G., Blom A. M. 2003a; Functional activity of the complement regulator encoded by Kaposi's sarcoma-associated herpesvirus. J Biol Chem 278:9283–9289 [CrossRef]
     [Google Scholar]
  202. Spiller O. B., Robinson M., O'Donnell E., Milligan S., Morgan B. P., Davison A. J., Blackbourn D. J. 2003b; Complement regulation by Kaposi's sarcoma-associated herpesvirus ORF4 protein. J Virol 77:592–599 [CrossRef]
     [Google Scholar]
  203. Spiller O. B., Mark L., Blue C. E., Proctor D. G., Aitken J. A., Blom A. M., Blackbourn D. J. 2006; Dissecting the regions of virion-associated Kaposi's sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding. J Virol 80:4068–4078 [CrossRef]
     [Google Scholar]
  204. Stark G. R., Kerr I. M., Williams B. R. G., Silverman R. H., Schreiber R. D. 1998; How cells respond to interferons. Annu Rev Biochem 67:227–264 [CrossRef]
     [Google Scholar]
  205. Staskus K. A., Zhong W., Gebhard K. & 8 other authors 1997; Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 71:715–719
     [Google Scholar]
  206. Staskus K. A., Sun R., Miller G., Racz P., Jaslowski A., Metroka C., Brett-Smith H., Haase A. T. 1999; Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J Virol 73:4181–4187
     [Google Scholar]
  207. Stevenson P. G., Efstathiou S., Doherty P. C., Lehner P. J. 2000; Inhibition of MHC class I-restricted antigen presentation by γ 2-herpesviruses. Proc Natl Acad Sci U S A 97:8455–8460 [CrossRef]
     [Google Scholar]
  208. Stinchcombe J. C., Bossi G., Booth S., Griffiths G. M. 2001; The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity 15:751–761 [CrossRef]
     [Google Scholar]
  209. Stine J. T., Wood C., Hill M. & 12 other authors 2000; KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. Blood 95:1151–1157
     [Google Scholar]
  210. Stürzl M., Blasig C., Schreier A. & 10 other authors 1997; Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int J Cancer 72:68–71 [CrossRef]
     [Google Scholar]
  211. Sun Q., Zachariah S., Chaudhary P. M. 2003; The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF- κ B activation. J Biol Chem 278:52437–52445 [CrossRef]
     [Google Scholar]
  212. Talbot S. J., Weiss R. A., Kellam P., Boshoff C. 1999; Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. Virology 257:84–94 [CrossRef]
     [Google Scholar]
  213. Tanaka N., Taniguchi T. 2000; The interferon regulatory factors and oncogenesis. Semin Cancer Biol 10:73–81 [CrossRef]
     [Google Scholar]
  214. Taniguchi T., Takaoka A. 2002; The interferon- α/β system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr Opin Immunol 14:111–116 [CrossRef]
     [Google Scholar]
  215. Taylor J. L., Bennett H. N., Snyder B. A., Moore P. S., Chang Y. 2005; Transcriptional analysis of latent and inducible Kaposi's sarcoma-associated herpesvirus transcripts in the K4 to K7 region. J Virol 79:15099–15106 [CrossRef]
     [Google Scholar]
  216. Thome M., Schneider P., Hofmann K. & 11 other authors 1997; Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517–521 [CrossRef]
     [Google Scholar]
  217. Tomasec P., Wang E. C. Y., Davison A. J. & 10 other authors 2005; Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nat Immunol 6:181–188
     [Google Scholar]
  218. Tomkowicz B., Singh S. P., Lai D., Singh A., Mahalingham S., Joseph J., Srivastava S., Srinivasan A. 2005; Mutational analysis reveals an essential role for the LXXLL motif in the transformation function of the human herpesvirus-8 oncoprotein, kaposin. DNA Cell Biol 24:10–20 [CrossRef]
     [Google Scholar]
  219. Tomlinson C. C., Damania B. 2004; The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway. J Virol 78:1918–1927 [CrossRef]
     [Google Scholar]
  220. Trautmann A., Valitutti S. 2003; The diversity of immunological synapses. Curr Opin Immunol 15:249–254 [CrossRef]
     [Google Scholar]
  221. Usherwood E. J., Meadows S. K., Crist S. G., Bellfy S. C., Sentman C. L. 2005; Control of murine gammaherpesvirus infection is independent of NK cells. Eur J Immunol 35:2956–2961 [CrossRef]
     [Google Scholar]
  222. Verschuren E. W., Klefstrom J., Evan G. I., Jones N. 2002; The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo. Cancer Cell 2:229–241 [CrossRef]
     [Google Scholar]
  223. Vilcek J. 2003; Novel interferons. Nat Immunol 4:8–9
     [Google Scholar]
  224. Wang H.-W., Sharp T. V., Koumi A., Koentges G., Boshoff C. 2002; Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin. EMBO J 21:2602–2615 [CrossRef]
     [Google Scholar]
  225. Watanabe I., Ross T. M., Tamura S. & 8 other authors 2003; Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin. Vaccine 21:4532–4538 [CrossRef]
     [Google Scholar]
  226. Waterston A., Bower M. 2004; Fifty years of multicentric Castleman's disease. Acta Oncol 43:698–704 [CrossRef]
     [Google Scholar]
  227. Weaver B. K., Kumar K. P., Reich N. C. 1998; Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol Cell Biol 18:1359–1368
     [Google Scholar]
  228. Weber K. S. C., Gröne H. J., Röcken M., Klier C., Gu S., Wank R., Proudfoot A. E. I., Nelson P. J., Weber C. 2001; Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II. Eur J Immunol 31:2458–2466 [CrossRef]
     [Google Scholar]
  229. Weber F., Bridgen A., Fazakerley J. K., Streitenfeld H., Kessler N., Randall R. E., Elliott R. M. 2002; Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. J Virol 76:7949–7955 [CrossRef]
     [Google Scholar]
  230. Widmer I., Wernli M., Bachmann F., Gudat F., Cathomas G., Erb P. 2002; Differential expression of viral Bcl-2 encoded by Kaposi's sarcoma-associated herpesvirus and human Bcl-2 in primary effusion lymphoma cells and Kaposi's sarcoma lesions. J Virol 76:2551–2556 [CrossRef]
     [Google Scholar]
  231. Wright G. J., Puklavec M. J., Willis A. C., Hoek R. M., Sedgwick J. D., Brown M. H., Barclay A. N. 2000; Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 13:233–242 [CrossRef]
     [Google Scholar]
  232. Wright G. J., Jones M., Puklavec M. J., Brown M. H., Barclay A. N. 2001; The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans. Immunology 102:173–179 [CrossRef]
     [Google Scholar]
  233. Wright G. J., Cherwinski H., Foster-Cuevas M. & 12 other authors 2003; Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J Immunol 171:3034–3046 [CrossRef]
     [Google Scholar]
  234. Yang T.-Y., Chen S.-C., Leach M. W. & 8 other authors 2000; Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med 191:445–454 [CrossRef]
     [Google Scholar]
  235. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T. 2004; The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730–737 [CrossRef]
     [Google Scholar]
  236. Young L. S., Rickinson A. B. 2004; Epstein–Barr virus: 40 years on. Nat Rev Cancer 4:757–768 [CrossRef]
     [Google Scholar]
  237. Young D. F., Didcock L., Goodbourn S., Randall R. E. 2000; Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology 269:383–390 [CrossRef]
     [Google Scholar]
  238. Yu Y., Wang S. E., Hayward G. S. 2005; The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 22:59–70 [CrossRef]
     [Google Scholar]
  239. Zhang S., Cherwinski H., Sedgwick J. D., Phillips J. H. 2004; Molecular mechanisms of CD200 inhibition of mast cell activation. J Immunol 173:6786–6793 [CrossRef]
     [Google Scholar]
  240. Zhong W., Wang H., Herndier B., Ganem D. 1996; Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci U S A 93:6641–6646 [CrossRef]
     [Google Scholar]
  241. Zhu F. X., Yuan Y. 2003; The ORF45 protein of Kaposi's sarcoma-associated herpesvirus is associated with purified virions. J Virol 77:4221–4230 [CrossRef]
     [Google Scholar]
  242. Zhu F. X., King S. M., Smith E. J., Levy D. E., Yuan Y. 2002; A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proc Natl Acad Sci U S A 99:5573–5578 [CrossRef]
     [Google Scholar]
  243. Zimring J. C., Goodbourn S., Offermann M. K. 1998; Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J Virol 72:701–707
     [Google Scholar]
  244. Zong J.-C., Ciufo D. M., Alcendor D. J. & 14 other authors 1999; High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J Virol 73:4156–4170
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81919-0
Loading
Kaposi's sarcoma-associated herpesvirus immune modulation: an overview
J. Gen. Virol. 87, 1781 (2006); https://doi.org/10.1099/vir.0.81919-0
/content/journal/jgv/10.1099/vir.0.81919-0
/content/journal/jgv/10.1099/vir.0.81919-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error